The application of lag times in cancer pharmacoepidemiology: a narrative review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The application of lag times in cancer pharmacoepidemiology: a narrative review

Published:2023-08 Issue: Volume:84 Page:25-32
ISSN:1047-2797
Container-title:Annals of Epidemiology
language:en
Short-container-title:Annals of Epidemiology

Author:

Hicks Blánaid^ORCID,Kaye James A.,Azoulay Laurent,Kristensen Kasper Bruun,Habel Laurel A.,Pottegård Anton

Publisher

Elsevier BV

Subject

Epidemiology

Reference97 articles.

1. Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail;Pound;J Transl Med,2018

2. The promise of pharmacoepidemiology in helping clinicians assess drug risk;Avorn;Circulation,2013

3. Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safety;Pinheiro;Ann Epidemiol,2016

4. Epidemiology, multistage models, and short-term mutagenicity tests;Peto;Int J Epidemiol,2016

5. Considerations for pharmacoepidemiological studies of drug–cancer associations;Pottegård;Basic Clin Pharmacol Toxicol,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase-5 Inhibitors and Dementia Risk: A Real-World Study;Neuroepidemiology;2024-06-27

2. The effect of colchicine on cancer risk in patients with immune-mediated inflammatory diseases: a time-dependent study based on the Taiwan’s National Health Insurance Research Database;European Journal of Medical Research;2024-04-22

3. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study;BMJ;2024-04-10

4. Use of 5‐alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: A population‐based cohort study;International Journal of Cancer;2024-03-30

5. Sodium‐glucose cotransporter‐2 inhibitors and the risk of lung cancer among patients with type 2 diabetes;British Journal of Clinical Pharmacology;2024-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3